Business Segment and Geographical Information (Tables)

9 Months Ended

Sep. 26, 2020

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

Business Segment Information

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
(In millions)	2020		2019		2020		2019
Revenues
Life Sciences Solutions	$	3,424	$	1,701	$	7,800	$	5,018
Analytical Instruments	1,336		1,358		3,488		4,004
Specialty Diagnostics	1,430		879		3,376		2,779
Laboratory Products and Services	3,112		2,619		8,629		7,765
Eliminations	(781)		(285)		(1,625)		(853)
Consolidated revenues	8,521		6,272		21,668		18,713
Segment Income (a)
Life Sciences Solutions	1,879		586		3,788		1,756
Analytical Instruments	171		311		477		879
Specialty Diagnostics	398		223		848		707
Laboratory Products and Services	355		303		931		933
Subtotal reportable segments (a)	2,803		1,423		6,044		4,275
Cost of revenues charges, net	(1)		(5)		(5)		(16)
Selling, general and administrative credits (charges), net	55		(7)		7		(54)
Restructuring and other (costs) income, net	(17)		(31)		(67)		442
Amortization of acquisition-related intangible assets	(414)		(434)		(1,256)		(1,285)
Consolidated operating income	2,426		946		4,723		3,362
Interest income (b)	9		52		53		179
Interest expense (b)	(144)		(164)		(407)		(534)
Other (expense) income, net (b)	(39)		(12)		(36)		25
Income before income taxes	$	2,252	$	822	$	4,333	$	3,032

(a)Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs/income, net; and amortization of acquisition-related intangibles.

(b)The company does not allocate interest or other expense/income, net to its segments.

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

Business Segment Information

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
(In millions)	2020		2019		2020		2019
Revenues
Life Sciences Solutions	$	3,424	$	1,701	$	7,800	$	5,018
Analytical Instruments	1,336		1,358		3,488		4,004
Specialty Diagnostics	1,430		879		3,376		2,779
Laboratory Products and Services	3,112		2,619		8,629		7,765
Eliminations	(781)		(285)		(1,625)		(853)
Consolidated revenues	8,521		6,272		21,668		18,713
Segment Income (a)
Life Sciences Solutions	1,879		586		3,788		1,756
Analytical Instruments	171		311		477		879
Specialty Diagnostics	398		223		848		707
Laboratory Products and Services	355		303		931		933
Subtotal reportable segments (a)	2,803		1,423		6,044		4,275
Cost of revenues charges, net	(1)		(5)		(5)		(16)
Selling, general and administrative credits (charges), net	55		(7)		7		(54)
Restructuring and other (costs) income, net	(17)		(31)		(67)		442
Amortization of acquisition-related intangible assets	(414)		(434)		(1,256)		(1,285)
Consolidated operating income	2,426		946		4,723		3,362
Interest income (b)	9		52		53		179
Interest expense (b)	(144)		(164)		(407)		(534)
Other (expense) income, net (b)	(39)		(12)		(36)		25
Income before income taxes	$	2,252	$	822	$	4,333	$	3,032

(a)Represents operating income before certain charges to cost of revenues and selling, general and administrative expenses; restructuring and other costs/income, net; and amortization of acquisition-related intangibles.

(b)The company does not allocate interest or other expense/income, net to its segments.

Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]

Geographical Information

	Three Months Ended				Nine Months Ended
	September 26,		September 28,		September 26,		September 28,
(In millions)	2020		2019		2020		2019
Revenues (c)
United States	$	4,428	$	3,096	$	10,981	$	9,117
China	828		694		1,886		2,072
Other	3,265		2,482		8,801		7,524
Consolidated revenues	$	8,521	$	6,272	$	21,668	$	18,713

(c)     Revenues are attributed to countries based on customer location.